2-MDP
跳至導覽
跳至搜尋
| File:2-MDP.svg | |
| 識別資訊 | |
|---|---|
| |
| CAS號 | 14326-31-9 check 14185-05-8 check |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| E編碼 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤:attempt to index field 'wikibase' (a nil value) |
| 化學資訊 | |
| 化學式 | C16H19NO |
| 摩爾質量 | 241.33 g·mol−1 |
| 3D模型(JSmol) | |
| |
2-MDP也稱為U-23807A是一種含氮有機化合物,分子式C
16H
19NO,為Upjohn研發的NMDA受體拮抗劑,在動物體內有苯環己哌啶(PCP)類似的功效,可作為解離劑和麻醉劑[1][2]。
參考文獻[編輯]
- ^ Tang AH, Cangelosi AA, Code RA, Franklin SR. Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP). Pharmacology, Biochemistry, and Behavior. February 1984, 20 (2): 209–213. PMID 6718449. S2CID 38908019. doi:10.1016/0091-3057(84)90244-2.
- ^ Blake JC, Davies SN, Church J, Martin D, Lodge D. 2-Methyl-3,3-diphenyl-3-propanolamine (2-MDP) selectively antagonises N-methyl-aspartate (NMA). Pharmacology, Biochemistry, and Behavior. January 1986, 24 (1): 23–25. PMID 3511477. S2CID 29762524. doi:10.1016/0091-3057(86)90038-9.
- ^ Moffett RB, Pickering TL. Central nervous system agents. 2. Synthesis of diphenyl primary and secondary aminopropanols. Journal of Medicinal Chemistry. November 1971, 14 (11): 1100–1106. PMID 5115211. doi:10.1021/jm00293a019.